Amexdrug Corporation

$0.00 0.00%(+$0.00)
TickerSpark Score
60/100
Mixed
87
Valuation
55
Profitability
55
Growth
75
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AXRX research report →

52-Week Range100% of range
Low
$0.00
Current
$0.00
High
$0.00
Company Overviewwww.amexdrug.com

About the company

Amexdrug Corporation, founded in 1963 and headquartered in Commerce, California, operates as a pharmaceutical and cosmeceutical enterprise. Primarily, the company, via its subsidiaries, distributes pharmaceutical products. Beyond this core function, Amexdrug is also deeply involved in the entire lifecycle of pharmaceutical drugs, cosmetics, and medical devices, from their research and development phases through manufacturing and ultimate sale.

CEO
Jack Amin
IPO
2001
Employees
9
HQ
Commerce, CA, US

Price Chart

+100.00% · this period
$0.00$0.00$0.00Jul 02Dec 31Jul 02
Valuation
Market Cap
$33.88K
P/E
0.40
P/S
0.01
P/B
0.02
EV/EBITDA
2.73
Div Yield
0.00%
Profitability
Gross Margin
45.96%
Op Margin
4.94%
Net Margin
1.73%
ROE
2.84%
ROIC
6.51%
Growth & Income
Revenue
$2.90M · -14.61%
Net Income
$40.27K · 252.18%
EPS
$0.00 · 100.00%
Op Income
$136.79K
FCF YoY
0.00%
Performance & Tape
52W High
$0.00
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
-0.55
Avg Volume
69

Get TickerSpark's AI analysis on AXRX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · AXRX

Our AXRX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on AXRX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate AXRX report →
Internal Compare

Similar companies

Peers in the same neighborhood.